AMGEN INC Total Liabilities 2008-2026 | AMGN
Beta
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is AMGEN INC's current total liabilities?
AMGEN INC (AMGN) annual total liabilities for 2025 was $81.93B, a 4.69% decline from 2024. AMGEN INC total liabilities for the quarter ending March 31, 2026 was $83.31B.
What was AMGEN INC's total liabilities in 2024?
AMGEN INC annual total liabilities for 2024 was $85.96B, a 5.46% decline from 2023.
What was AMGEN INC's total liabilities in 2023?
AMGEN INC annual total liabilities for 2023 was $90.92B, a 47.94% increase from 2022.
What is AMGEN INC's 5-year total liabilities CAGR?
AMGEN INC total liabilities grew at a compound annual growth rate (CAGR) of 8.88% from FY2020 to FY2025, going from $53.54B to $81.93B over 5 years.
Total Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR+8.9%
FY2020
$53.54B
→
FY2025
$81.93B
080910111213141516171819202122232425
5 years selected
Total Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $81.93B | -4.7% | 10-K |
| FY2024 | $85.96B | -5.5% | 10-K |
| FY2023 | $90.92B | +47.9% | 10-K |
| FY2022 | $61.46B | +12.8% | 10-K |
| FY2021 | $54.47B | +1.7% | 10-K |
| FY2020 | $53.54B | +7.0% | 10-K |
| FY2019 | $50.03B | -7.2% | 10-K |
| FY2018 | $53.92B | -1.5% | 10-K |
| FY2017 | $54.71B | +14.6% | 10-K |
| FY2016 | $47.75B | +10.1% | 10-K |
| FY2015 | $43.37B | +0.3% | 10-K |
| FY2014 | $43.23B | -1.8% | 10-K |
| FY2013 | $44.03B | +24.9% | 10-K |
| FY2012 | $35.24B | +18.1% | 10-K |
| FY2011 | $29.84B | +52.7% | 10-K |
| FY2010 | $19.54B | +15.2% | 10-K |
| FY2009 | $16.96B | +9.1% | 10-K |
| FY2008 | $15.54B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →